Xeris Biopharma Holdings Dividend
Dividend criteria checks 0/6
Xeris Biopharma Holdings does not have a record of paying a dividend.
|Industry average yield
|Next dividend pay date
|Ex dividend date
|Dividend per share
|Earnings per share
|Dividend yield forecast in 3Y
Recent dividend updates
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Fly 32% But Investors Aren't Buying For GrowthJan 05
Xeris Pharmaceuticals Q2 2022 Earnings PreviewAug 09
Xeris amends commercial terms for hypoglycemia therapy as partner inks buyout dealAug 01
Xeris Biopharma: Q1 Earnings Reveal Path To BreakevenMay 21
Xeris Continues To Execute And Build Long-Term Value PotentialFeb 22
Xeris Biopharma: Market Is Snubbing The Strongbridge AcquisitionDec 20
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if XERS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if XERS's dividend payments have been increasing.
Dividend Yield vs Market
|Xeris Biopharma Holdings Dividend Yield vs Market
|Market Bottom 25% (US)
|Market Top 25% (US)
|Industry Average (Pharmaceuticals)
|Analyst forecast in 3 Years (XERS)
Notable Dividend: Unable to evaluate XERS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate XERS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate XERS's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as XERS has not reported any payouts.